{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:37:49Z","timestamp":1789400269417,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014452","name":"University of Cincinnati College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.molmet.2026.102365","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:21:20Z","timestamp":1776295280000},"page":"102365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["GIPR:GCGR co-agonism restores normal weight in obese rodents"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-4133","authenticated-orcid":false,"given":"Diego","family":"Perez-Tilve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Lohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Sorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo D.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-371X","authenticated-orcid":false,"given":"Matthias H.","family":"Tsch\u00f6p","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0220-4085","authenticated-orcid":false,"given":"Richard D.","family":"DiMarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.molmet.2026.102365_bib1","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.cell.2024.06.003","article-title":"Transforming obesity: the advancement of multi-receptor drugs","volume":"187","author":"Kusminski","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.molmet.2026.102365_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"Muller","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.molmet.2026.102365_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.molmet.2026.102365_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1152\/physrev.00025.2016","article-title":"The new biology and pharmacology of glucagon","volume":"97","author":"Muller","year":"2017","journal-title":"Physiol Rev"},{"issue":"8","key":"10.1016\/j.molmet.2026.102365_bib5","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s00125-023-05947-y","article-title":"100 years of glucagon and 100 more","volume":"66","author":"Wewer Albrechtsen","year":"2023","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.molmet.2026.102365_bib6","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.cmet.2022.10.001","article-title":"The past, present, and future physiology and pharmacology of glucagon","volume":"34","author":"Capozzi","year":"2022","journal-title":"Cell Metab"},{"issue":"4575","key":"10.1016\/j.molmet.2026.102365_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1126\/science.7134979","article-title":"Stimulation of feeding in rats by intraperitoneal injection of antibodies to glucagon","volume":"218","author":"Langhans","year":"1982","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.molmet.2026.102365_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrendo.2010.187","article-title":"The metabolic actions of glucagon revisited","volume":"6","author":"Habegger","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.molmet.2026.102365_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0149-7634(05)80042-9","article-title":"Pancreatic glucagon signals postprandial satiety","volume":"14","author":"Geary","year":"1990","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.molmet.2026.102365_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm.3761","article-title":"A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents","volume":"21","author":"Finan","year":"2015","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.molmet.2026.102365_bib11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"issue":"10401","key":"10.1016\/j.molmet.2026.102365_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(23)01053-X","article-title":"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA","volume":"402","author":"Rosenstock","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.molmet.2026.102365_bib13","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial","volume":"30","author":"Sanyal","year":"2024","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.molmet.2026.102365_bib14","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/s42255-023-00931-7","article-title":"Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice","volume":"5","author":"Liskiewicz","year":"2023","journal-title":"Nat Metab"},{"issue":"4","key":"10.1016\/j.molmet.2026.102365_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmet.2021.01.015","article-title":"The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.molmet.2026.102365_bib16","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmet.2022.07.013","article-title":"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept","volume":"34","author":"Coskun","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2026.102365_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101533","article-title":"Next generation GLP-1\/GIP\/glucagon triple agonists normalize body weight in obese mice","volume":"63","author":"Knerr","year":"2022","journal-title":"Mol Metabol"},{"issue":"1","key":"10.1016\/j.molmet.2026.102365_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmet.2021.12.005","article-title":"Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1\/GIP\/GCG receptor triagonist","volume":"34","author":"Bossart","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2026.102365_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"Muller","year":"2019","journal-title":"Mol Metabol"},{"issue":"8025","key":"10.1016\/j.molmet.2026.102365_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-024-07685-6","article-title":"Dissociable hindbrain GLP1R circuits for satiety and aversion","volume":"632","author":"Huang","year":"2024","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.molmet.2026.102365_bib21","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1523\/JNEUROSCI.22-23-10470.2002","article-title":"The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness","volume":"22","author":"Kinzig","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.molmet.2026.102365_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2013.01.013","article-title":"Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew)","volume":"70","author":"Chan","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.molmet.2026.102365_bib23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/en.2004-0419","article-title":"The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: differential effects in rats and mice","volume":"146","author":"Lachey","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2026.102365_bib24","article-title":"Recent achievements and future directions of anti-obesity medications","volume":"47","author":"Grandl","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"11","key":"10.1016\/j.molmet.2026.102365_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(25)00226-8","article-title":"Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial","volume":"13","author":"Wharton","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.molmet.2026.102365_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered cagrilintide and semaglutide in adults with overweight or obesity","volume":"393","author":"Garvey","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.molmet.2026.102365_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4093\/dmj.2025.0242","article-title":"Exploring the side effects of GLP-1 receptor agonist: to ensure its optimal positioning","volume":"49","author":"Kim","year":"2025","journal-title":"Diabetes Metab J"},{"issue":"10","key":"10.1016\/j.molmet.2026.102365_bib28","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/s41366-025-01859-6","article-title":"Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis","volume":"49","author":"Ismaiel","year":"2025","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.molmet.2026.102365_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.molmet.2026.102365_bib30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nchembio.209","article-title":"A new glucagon and GLP-1 co-agonist eliminates obesity in rodents","volume":"5","author":"Day","year":"2009","journal-title":"Nat Chem Biol"},{"issue":"7","key":"10.1016\/j.molmet.2026.102365_bib31","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.2337\/db12-1498","article-title":"Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency","volume":"62","author":"Wilson-Perez","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2026.102365_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2026.102365_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102298","article-title":"Long-acting GIPR agonist LY3537021 reduces body weight and fasting blood glucose in patients with T2D: preclinical development and phase 1 randomized ascending dose studies","volume":"103","author":"Roell","year":"2026","journal-title":"Mol Metabol"},{"issue":"3","key":"10.1016\/j.molmet.2026.102365_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/acel.12576","article-title":"Sterol regulatory element-binding protein-1c orchestrates metabolic remodeling of white adipose tissue by caloric restriction","volume":"16","author":"Fujii","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.molmet.2026.102365_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.106217","article-title":"A unified rodent atlas reveals the cellular complexity and evolutionary divergence of the dorsal vagal complex","volume":"14","author":"Hes","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.molmet.2026.102365_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101945","article-title":"Stimulating intestinal GIP release reduces food intake and body weight in mice","volume":"84","author":"Lewis","year":"2024","journal-title":"Mol Metabol"},{"issue":"Suppl 1","key":"10.1016\/j.molmet.2026.102365_bib37","first-page":"S31","article-title":"Physiology of energy expenditure in the weight-reduced state","volume":"29","author":"Ravussin","year":"2021","journal-title":"Obesity (Silver Spring)"},{"issue":"29","key":"10.1016\/j.molmet.2026.102365_bib38","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1523\/JNEUROSCI.2876-19.2020","article-title":"Acute inflammation alters brain energy metabolism in mice and humans: role in suppressed spontaneous activity, impaired cognition, and delirium","volume":"40","author":"Kealy","year":"2020","journal-title":"J Neurosci"},{"issue":"19","key":"10.1016\/j.molmet.2026.102365_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194798","article-title":"Activity in group-housed home cages of mice as a novel preclinical biomarker in oncology studies","volume":"15","author":"Terry","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.molmet.2026.102365_bib40","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.cmet.2024.07.023","article-title":"Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease","volume":"36","author":"Petersen","year":"2024","journal-title":"Cell Metab"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826000499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826000499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:18:33Z","timestamp":1781756313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877826000499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S2212877826000499"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102365","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GIPR:GCGR co-agonism restores normal weight in obese rodents","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102365"}}